Granisetron (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Granisetron" in Italian language version.

refsWebsite

Global rank Italian rank

15nih.gov

4^th place

9^th place

5oadoi.org

799^th place

22^nd place

5doi.org

2^nd place

7^th place

doi.org

dx.doi.org

P. Feyer, MH. Seegenschmiedt; M. Steingraeber, Granisetron in the control of radiotherapy-induced nausea and vomiting: a comparison with other antiemetic therapies., in Support Care Cancer, vol. 13, n. 9, Set 2005, pp. 671-8, DOI:10.1007/s00520-004-0766-3, PMID 16044252.
F. Roila, PJ. Hesketh; J. Herrstedt, Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference., in Ann Oncol, vol. 17, n. 1, Gen 2006, pp. 20-8, DOI:10.1093/annonc/mdj078, PMID 16314401.
SL. Corman, SJ. Skledar; NT. Ansani, Low-dose granisetron for postoperative nausea and vomiting prophylaxis., in Ann Pharmacother, vol. 38, n. 4, Apr 2004, pp. 710-3, DOI:10.1345/aph.1D328, PMID 14982978.
A. Ganjare, AP. Kulkarni, Comparative electrocardiographic effects of intravenous ondansetron and granisetron in patients undergoing surgery for carcinoma breast: A prospective single-blind randomised trial., in Indian J Anaesth, vol. 57, n. 1, Gen 2013, pp. 41-5, DOI:10.4103/0019-5049.108560, PMID 23716765.
FG. Pinarli, M. Elli; A. Dagdemir; K. Baysal; S. Acar, Electrocardiographic findings after 5-HT3 receptor antagonists and chemotherapy in children with cancer., in Pediatr Blood Cancer, vol. 47, n. 5, Ott 2006, pp. 567-71, DOI:10.1002/pbc.20639, PMID 16317736.

nih.gov

ncbi.nlm.nih.gov

RA. Joss, J. Richner; KW. Brunner; D. Rohrbach; M. Pirovino; JP. Terrey; J. Upward, BRL 43694: a novel antiemetic to prevent nausea and vomiting induced by chemotherapy., in J Natl Cancer Inst, vol. 80, n. 16, Ott 1988, pp. 1340-1, PMID 2845107.
R. Joss, D. Rohrbach; K. Buser; M. Pirovino; C. Karde; K. Brunner, [BRL 43694A--a 5-hydroxytryptamine receptor blocker as an antiemetic in cytostatic therapy]., in Schweiz Med Wochenschr, vol. 119, n. 23, Giu 1989, pp. 831-4, PMID 2549616.
VR. Adams, AW. Valley, Granisetron: the second serotonin-receptor antagonist., in Ann Pharmacother, vol. 29, n. 12, Dic 1995, pp. 1240-51, PMID 8672830.
M. Krengli, R. Lazzari; M. Manara, [The use of granisetron per os in radiotherapy-induced emesis]., in Minerva Med, vol. 87, n. 12, Dic 1996, pp. 605-8, PMID 9064597.
P. Feyer, MH. Seegenschmiedt; M. Steingraeber, Granisetron in the control of radiotherapy-induced nausea and vomiting: a comparison with other antiemetic therapies., in Support Care Cancer, vol. 13, n. 9, Set 2005, pp. 671-8, DOI:10.1007/s00520-004-0766-3, PMID 16044252.
F. Roila, PJ. Hesketh; J. Herrstedt, Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference., in Ann Oncol, vol. 17, n. 1, Gen 2006, pp. 20-8, DOI:10.1093/annonc/mdj078, PMID 16314401.
J. Carmichael, BM. Cantwell; CM. Edwards; WG. Rapeport; AL. Harris, The serotonin type 3 receptor antagonist BRL 43694 and nausea and vomiting induced by cisplatin., in BMJ, vol. 297, n. 6641, Lug 1988, pp. 110-1, PMID 2841996.
YE. Yarker, D. McTavish, Granisetron. An update of its therapeutic use in nausea and vomiting induced by antineoplastic therapy., in Drugs, vol. 48, n. 5, Nov 1994, pp. 761-93, PMID 7530631.
AJ. Wilson, P. Diemunsch; BG. Lindeque; H. Scheinin; HS. Helbo-Hansen; MV. Kroeks; KL. Kong, Single-dose i.v. granisetron in the prevention of postoperative nausea and vomiting., in Br J Anaesth, vol. 76, n. 4, Apr 1996, pp. 515-8, PMID 8652323.
SL. Corman, SJ. Skledar; NT. Ansani, Low-dose granisetron for postoperative nausea and vomiting prophylaxis., in Ann Pharmacother, vol. 38, n. 4, Apr 2004, pp. 710-3, DOI:10.1345/aph.1D328, PMID 14982978.
GL. Plosker, KL. Goa, Granisetron. A review of its pharmacological properties and therapeutic use as an antiemetic., in Drugs, vol. 42, n. 5, Nov 1991, pp. 805-24, PMID 1723376.
M. Aapro, M. Rabaeus, Re: The effects of ondansetron and granisetron on electrocardiography in children receiving chemotherapy for acute leukemia., in Am J Clin Oncol, vol. 28, n. 6, Dic 2005, pp. 634-5, PMID 16317278.
I. Oztop, M. Gencer; T. Okan; A. Yaren; E. Altekin; S. Turker; U. Yilmaz, Evaluation of cardiotoxicity of a combined bolus plus infusional 5-fluorouracil/folinic acid treatment by echocardiography, plasma troponin I level, QT interval and dispersion in patients with gastrointestinal system cancers., in Jpn J Clin Oncol, vol. 34, n. 5, Mag 2004, pp. 262-8, PMID 15231861.
A. Ganjare, AP. Kulkarni, Comparative electrocardiographic effects of intravenous ondansetron and granisetron in patients undergoing surgery for carcinoma breast: A prospective single-blind randomised trial., in Indian J Anaesth, vol. 57, n. 1, Gen 2013, pp. 41-5, DOI:10.4103/0019-5049.108560, PMID 23716765.
FG. Pinarli, M. Elli; A. Dagdemir; K. Baysal; S. Acar, Electrocardiographic findings after 5-HT3 receptor antagonists and chemotherapy in children with cancer., in Pediatr Blood Cancer, vol. 47, n. 5, Ott 2006, pp. 567-71, DOI:10.1002/pbc.20639, PMID 16317736.

oadoi.org

P. Feyer, MH. Seegenschmiedt; M. Steingraeber, Granisetron in the control of radiotherapy-induced nausea and vomiting: a comparison with other antiemetic therapies., in Support Care Cancer, vol. 13, n. 9, Set 2005, pp. 671-8, DOI:10.1007/s00520-004-0766-3, PMID 16044252.
F. Roila, PJ. Hesketh; J. Herrstedt, Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference., in Ann Oncol, vol. 17, n. 1, Gen 2006, pp. 20-8, DOI:10.1093/annonc/mdj078, PMID 16314401.
SL. Corman, SJ. Skledar; NT. Ansani, Low-dose granisetron for postoperative nausea and vomiting prophylaxis., in Ann Pharmacother, vol. 38, n. 4, Apr 2004, pp. 710-3, DOI:10.1345/aph.1D328, PMID 14982978.
A. Ganjare, AP. Kulkarni, Comparative electrocardiographic effects of intravenous ondansetron and granisetron in patients undergoing surgery for carcinoma breast: A prospective single-blind randomised trial., in Indian J Anaesth, vol. 57, n. 1, Gen 2013, pp. 41-5, DOI:10.4103/0019-5049.108560, PMID 23716765.
FG. Pinarli, M. Elli; A. Dagdemir; K. Baysal; S. Acar, Electrocardiographic findings after 5-HT3 receptor antagonists and chemotherapy in children with cancer., in Pediatr Blood Cancer, vol. 47, n. 5, Ott 2006, pp. 567-71, DOI:10.1002/pbc.20639, PMID 16317736.